@article{680b9af0484546dea8f752be3470e99f,
title = "Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: A phase i study",
author = "U. Platzbecker and F. Braulke and A. K{\"u}ndgen and K. G{\"o}tze and G. Bug and C. Sch{\"o}nefeldt and K. Shirneshan and C. R{\"o}llig and M. Bornh{\"a}user and R. Naumann and J. Neesen and A. Giagounidis and Hofmann, {W. K.} and G. Ehninger and U. Germing and D. Haase and M. Wermke",
note = "Funding Information: We thank the investigators of the Groupe Francophone des My{\'e}lodysplasies and Groupe Ouest-Est d{\textquoteright}{\'e}tude des Leuc{\'e}mies Aigu{\"e}s et Autres Maladies du Sang for including patients, and M Bourmaud for technical assistance. This study was supported by grant no. 109686 from the Deutsche Krebshilfe awarded to FD and grants from the Program Hospitalier de Recherche Clinique (MDS-04 to MF and MYELOMONO to ES), Association Laurette Fugain (to ND), Ligue Nationale Contre le Cancer (to OAB and to ES) and INCa translational research grants (to MF, and to ES). Funding Information: U Platzbecker, U Germing and D Haase have received honoraria and research funding from Celgene Corporation. A K{\"u}ndgen, K G{\"o}tze, M Bornh{\"a}user, A Giagounidis and W-K. Hofmann have received honoraria from Celgene Corporation. The remaining authors declare no conflict of interest.",
year = "2013",
month = jun,
doi = "10.1038/leu.2013.26",
language = "English",
volume = "27",
pages = "1403--1407",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Springer Nature",
number = "6",
}
